Vivos Therapeutics, Inc.
VVOS · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $33,987 | $28,716 | $24,497 | $25,266 |
| - Cash | $3,087 | $4,402 | $2,342 | $6,260 |
| + Debt | $4,119 | $11,581 | $1,399 | $1,512 |
| Enterprise Value | $35,019 | $35,895 | $23,554 | $20,518 |
| Revenue | $6,783 | $3,820 | $3,016 | $3,698 |
| % Growth | 77.6% | 26.7% | -18.4% | – |
| Gross Profit | $3,937 | $2,110 | $1,509 | $2,097 |
| % Margin | 58% | 55.2% | 50% | 56.7% |
| EBITDA | -$5,016 | -$4,707 | -$3,564 | -$2,683 |
| % Margin | -73.9% | -123.2% | -118.2% | -72.6% |
| Net Income | -$5,400 | -$5,013 | -$3,864 | -$2,827 |
| % Margin | -79.6% | -131.2% | -128.1% | -76.4% |
| EPS Diluted | -0.49 | -0.55 | -0.45 | -0.48 |
| % Growth | 10.9% | -22.2% | 6.2% | – |
| Operating Cash Flow | -$4,161 | -$3,494 | -$3,796 | -$2,940 |
| Capital Expenditures | $893 | -$771 | -$122 | -$165 |
| Free Cash Flow | -$3,268 | -$4,265 | -$3,796 | -$3,105 |